Paiontec Earns Top NICE D&B Technology Rating for Second Straight Year
TI-1 grade awarded in 2026 after 2025
'%25EC%2599%2580%2520'%25EB%25B3%25BC%25EB%25A5%25A8%25ED%2586%25A1%25EC%258A%25A4%2520%25EC%2598%25A4%25EB%25A6%25AC%25EC%25A7%2580%25EB%2584%2590(Volume%2520Tox%2520Original)'%2520%25EC%25A0%259C%25ED%2592%2588.(%25ED%258C%258C%25EC%259D%25B4%25EC%2598%25A8%25ED%2585%258D%2520%25EC%25A0%259C%25EA%25B3%25B5).jpg&w=3840&q=75&dpl=dpl_7wfQ8aETrSZMepbMDtMDMj4B9k4m)
Paiontec (파이온텍), a dermocosmetics company that develops products based on nano-bio technology, said on Nov. 9 that it had received TI-1, the highest grade in the technology evaluation run by ratings firm NICE D&B, in 2026 after receiving the same grade in 2025. The company is led by Chief Executive Kim Tae-gon.
TI-1 is the top grade in NICE D&B's 10-step scale, which assesses technological competitiveness, marketability, growth potential and commercialisation capability. With this year's result, Paiontec has been rated at that level for two consecutive years.
Paiontec's core technology is a transdermal delivery system, or TDDS, which carries active ingredients into the skin. The company combines spicules — microscopic needle-shaped structures whose form it controls precisely — with nano-scale carriers and its own formulation technology. It applies the technology to a range of raw materials and formulations for joint development with global brands and for contract manufacturing based on the technology.
The company is expanding along two lines: supplying its technology platform to other firms and building its own brands. Paiontec said it expects revenue this year to grow more than 200 percent from a year earlier, helped by wider global supply and more orders for higher-margin products.
In the United States, Paiontec is targeting consumers with its own brands Volume Tox and LAB GONY. LAB GONY, built around the idea of "beauty led by science," plans to offer creams using retinal, vitamins C and E and peptides, along with products that apply micro-spicules.
For distribution, the company is treating Amazon as its main sales channel and linking it to short-form content on TikTok and marketing through creators. Drawing on live-commerce experience built up on the Chinese platforms Douyin and Kuaishou, it plans to convert product interest into purchases and repeat purchases on Amazon, and to feed consumer data back into product development and marketing.
Paiontec has also put the groundwork for overseas sales in place. It has completed registration of its cosmetics manufacturing facility with the U.S. Food and Drug Administration. It has also set up internal procedures to handle product listings, safety substantiation and labelling requirements under the U.S. Modernization of Cosmetics Regulation Act (MoCRA). The company has obtained halal certification from the Korea Halal Authority (KHA) and the Korea Muslim Federation (KMF) as it prepares to enter Southeast Asian and Middle Eastern markets.
"Receiving TI-1 for two consecutive years is recognition of the technology and commercialisation competitiveness we have built up over more than 20 years," Kim said. "On the basis of our own TDDS technology and our digital commerce capability, we will go after the U.S. market and pursue our two growth strategies of supplying the technology platform and developing our own brands."
Distributed via neta.